IDEAS home Printed from https://ideas.repec.org/a/sae/clnure/v32y2023i4p705-711.html
   My bibliography  Save this article

Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes

Author

Listed:
  • Sabaa Masarwe
  • Rachel Shvartsur
  • Eran Hadar
  • Batya Betesh-Abay
  • Noam Peleg
  • Abed N. Azab

Abstract

Ondansetron is a widely administered medication for nausea and vomiting of pregnancy. Further examination of its teratogenic capacity is necessary. This study examines the association between ondansetron treatment during pregnancy and birth defects and adverse obstetric outcomes. Patient data were extracted from Clalit Health Services, Israel. A propensity-score analysis was performed matching those exposed to ondansetron with those who were not. Findings identified 774 women exposed to ondansetron, matched 1:1 with unexposed control patients. No significant differences were found between the groups for: cleft palate, cardiovascular congenital abnormalities, spina bifida occulta, preterm delivery, or small for gestational age. Ondansetron may be a useful and safe alternative as treatment for women who suffer from hyperemesis gravidarum and do not respond to other antiemetic drugs. Notwithstanding, additional prospectively designed research is needed to establish the safety of ondansetron treatment during pregnancy.

Suggested Citation

  • Sabaa Masarwe & Rachel Shvartsur & Eran Hadar & Batya Betesh-Abay & Noam Peleg & Abed N. Azab, 2023. "Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes," Clinical Nursing Research, , vol. 32(4), pages 705-711, May.
  • Handle: RePEc:sae:clnure:v:32:y:2023:i:4:p:705-711
    DOI: 10.1177/10547738231159062
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/10547738231159062
    Download Restriction: no

    File URL: https://libkey.io/10.1177/10547738231159062?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:clnure:v:32:y:2023:i:4:p:705-711. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.